Join
Live feed
·
INSIDERFilingvia Quantisnow
G1 Therapeutics Inc. logo

Umstead John W. V sold $2,298 worth of shares (743 units at $3.09) and was granted 37,300 shares, increasing direct ownership by 39% to 130,443 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GTHX (G1 Therapeutics Inc.) and more on Quantisnow.